There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.”

Be the second on Patreon:

👉 https://www.patreon.com/PearlsandPrep

We're diving deep into the world of Metformin today, folks! This little gem is often overlooked, but it’s a total game-changer for managing weight gain from antipsychotics. Seriously, we’re talking about a cheap, effective med that could save our patients from a whole lot of metabolic trouble. It’s wild that only about 2-3% of folks who could benefit from it are actually getting prescribed Metformin—talk about a missed opportunity! We're here to shake things up and help you feel more comfortable adding this powerhouse to your toolbox, because keeping our patients healthy and happy is what it’s all about. So buckle up, because we're about to unpack why this underdog deserves a spot in your practice!

27

Are We Missing One of Psychiatry’s Easiest Wins? (Metformin)

Pearls and Prep

[email protected]

https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink

Takeaways:

• Metformin is a total game changer for preventing weight gain with psych meds, seriously.
• A staggering 2 to 3% of folks who need Metformin for weight issues actually get it prescribed.
• Weight gain from antipsychotics is the number one reason for patients ditching their meds; we gotta fix this.
• We should be proactive with Metformin, not reactive; waiting is just bad news, fam.
• Understanding how Metformin works and its benefits is crucial for our practice, no doubt about it.
• Don't underestimate the power of a simple, cheap med like Metformin; it can save lives.

Companies mentioned in this episode:

• Metformin
• Zyprexa
• Seroquel
• Cymbalta
• Prozac
• Zoloft
• Geodon
• Abilify
• Latuda
• Risperdal

This podcast uses the following third-party services for analysis:

Podcorn - https://podcorn.com/privacy

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.”

Patients know the difference. Know the WHY!

Join our clinical library today on PATREON!

👉 https://www.patreon.com/PearlsandPrep

Prozac vs Zoloft: They Look the Same... But They're Not at All

Prozac (fluoxetine) and Zoloft (sertraline) are both SSRIs, both first-line treatments for depression, and both commonly prescribed for anxiety disorders—but they are far from interchangeable.

In this episode of Pearls & Prep, we go beyond the textbook to explore the practical clinical reasoning behind choosing Prozac vs Zoloft. You'll learn why one patient may thrive on Prozac while another is a much better fit for Zoloft—and how experienced psychiatric clinicians think through that decision.

We'll cover:

• Why Prozac's long half-life is both one of its greatest strengths and one of its biggest drawbacks

• Why Prozac is often easier to discontinue—but much harder to wash out when side effects occur

• The famous "little old lady getting off the bus" analogy for remembering fluoxetine's long half-life

• Why Zoloft is often the better choice in patients taking multiple medications because it has fewer clinically significant drug interactions

• Understanding CYP2D6 inhibition and why Prozac can increase levels of medications like Abilify, risperidone, tamoxifen, and others

• Why sertraline is generally considered more "flexible" in medically complex patients

• FDA approvals that actually matter in practice, including PTSD, PMDD, social anxiety disorder, panic disorder, OCD, bulimia nervosa, and depression

• Why Prozac remains the only FDA-approved SSRI for bulimia nervosa

• How Prozac becomes Symbyax when combined with olanzapine for bipolar I depression—and why that combination can be incredibly effective despite its metabolic tradeoffs

• Which medication is generally preferred during breastfeeding

• Differences in activation, insomnia, nausea, diarrhea, withdrawal symptoms, sexual dysfunction, and common adverse effects

• Why your own prescribing experiences can create bias—and how evidence-based medicine helps keep us honest

This episode isn't about memorizing medication facts. It's about learning how to think like a psychiatric prescriber. By the end, you'll understand not only the pharmacology behind fluoxetine and sertraline, but also the clinical reasoning that helps you confidently choose the right SSRI for the right patient.

Whether you're a PMHNP student, psychiatric nurse practitioner, psychiatry resident, physician assistant, medical student, or practicing mental health clinician, this episode will give you practical psychopharmacology pearls you can immediately apply in clinic and remember long after boards are over.

📚 Want even more sticky psychiatry?

Join the Pearls & Prep Patreon for:

• Premium visual psychopharmacology graphics
• Board Bombs study resources
• Weekly Pearl Drops
• Full psychiatry learning library
• Live mock patient simulations
• Personalized written feedback through the Mafia Pearl mentorship

👉 patreon.com/pearlsandprep

33

Prozac vs Zoloft: They Look the Same... But They're Not at All

Pearls and Prep

[email protected]

https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink

This podcast uses the following third-party services for analysis:

Podcorn - https://podcorn.com/privacy

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.”

Patients know the difference. Know the WHY!

Join our clinical library today on PATREON!

👉 https://www.patreon.com/PearlsandPrep

Episode Description

One patient. Three possible DSM-5 diagnoses. Only one is correct.

In this episode of Pearls & Prep, NPZ walks you through one of the most realistic—and challenging—psychiatric differential diagnoses you'll encounter in clinical practice. At first glance, this patient appears to meet criteria for PTSD, Major Depressive Disorder (MDD), and Adjustment Disorder simultaneously. But as you'll discover, great psychiatric diagnosis isn't about memorizing DSM criteria—it's about asking the right questions.

Using a real-world clinical case, we'll slow down the diagnostic process and examine how experienced psychiatric clinicians separate normal grief, adjustment disorder, major depression, and PTSD without rushing to label every emotional response as mental illness.

In this episode you'll learn:

• How to distinguish Adjustment Disorder vs Major Depressive Disorder

• When grief is normal—and when it becomes something more

• What actually qualifies as a Criterion A trauma for PTSD

• Why simply experiencing trauma does not automatically equal PTSD

• The interview questions that reveal the diagnosis hiding underneath the symptoms

• How guilt differs in depression versus trauma-related reactions

• The difference between circumscribed distress and global psychological impairment

• Why anhedonia and worthlessness are often more diagnostically useful than sadness alone

• Common mistakes new psychiatric providers make when diagnosing trauma and depression

• Practical interviewing pearls you can immediately use during psychiatric evaluations

Whether you're a PMHNP student, psychiatry resident, practicing clinician, or preparing for board exams, this episode will sharpen your diagnostic reasoning and help you avoid one of the most common—and most important—mistakes in psychiatric practice: treating the wrong disorder because multiple diagnoses appear to fit.

Remember: the quality of your diagnosis depends on the quality of your questions. Every medication decision, treatment plan, and patient outcome begins with getting the diagnosis right.

🎩 Want access to the full clinical vault?

Become a Boss Pearl on Patreon and unlock exclusive premium episodes, psychopharmacology deep dives, Board Bombs, interview pearls, downloadable clinical resources, and much more.

Looking for personalized coaching? Join the MAFIA Pearl™ tier for live psychiatric interview simulations, individualized written feedback, diagnostic coaching, medication selection guidance, and direct mentorship designed to accelerate your clinical confidence.

Practice psychiatry before it matters.

32

Would You Diagnose PTSD, Depression, or Adjustment Disorder? One Patient. Three Diagnoses. Key Clinical Pearls You Should Know That Separate Them.

Pearls and Prep

[email protected]

https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink

This podcast uses the following third-party services for analysis:

Podcorn - https://podcorn.com/privacy

How I Choose Antipsychotics in Real Clinical Practice: 4 Pearls That Will Transform Your Bipolar Prescribing

How do experienced psychiatric providers actually choose between Seroquel, Abilify, Latuda, Vraylar, Risperdal, Zyprexa, and Geodon? In this episode, I share the exact clinical framework I use every day when prescribing second-generation antipsychotics (SGAs) for bipolar disorder. Rather than memorizing medication lists, you'll learn four practical prescribing pearls that simplify complex decisions and help you match the right medication to the right patient.

We'll cover acute mania versus bipolar depression, maintenance therapy, medication receptor profiles, metabolic considerations, weight gain, sedation, akathisia, prolactin elevation, movement disorders, and how patient-specific goals should influence every prescribing decision. You'll also learn why treating the episode in front of you isn't enough—and why thinking one step ahead can dramatically improve long-term outcomes for your patients.

Whether you're a PMHNP student, psychiatry resident, physician assistant, psychiatric nurse practitioner, or practicing clinician, this episode will help you prescribe with greater confidence, stronger clinical reasoning, and a deeper understanding of why one antipsychotic may be a much better choice than another.

32

How I Choose Antipsychotics in Real Clinical Practice: 4 Pearls That Will Transform Your Bipolar Prescribing

Pearls and Prep

[email protected]

https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink

This podcast uses the following third-party services for analysis:

Podcorn - https://podcorn.com/privacy

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.”

Patients know the difference. Know the WHY!

Join our clinical library today on PATREON!

👉 https://www.patreon.com/PearlsandPrep

The 6 Reasons Experienced Clinicians Reach for Wellbutrin First | Pearls & Prep

Thinking about prescribing Wellbutrin (bupropion)? In this episode of Pearls & Prep, NPZ sits down for one of his favorite types of conversations—the kind that goes beyond randomized controlled trials and dives into how medications actually perform in everyday psychiatric practice. Drawing from years of clinical experience and thousands of psychiatric evaluations, NPZ shares the practical decision-making process behind one of psychiatry's most unique antidepressants.

You'll learn the six clinical reasons Wellbutrin frequently earns a place in NPZ's treatment toolbox, including why it stands apart from SSRIs like Prozac, Zoloft, and Lexapro. We discuss why Wellbutrin is often considered for patients concerned about weight gain or sexual dysfunction, why its dopaminergic and noradrenergic effects can be particularly helpful for patients struggling with fatigue, brain fog, low motivation, and anhedonia, and why many clinicians describe it as a medication that helps patients "get moving again."

This episode also explores situations where Wellbutrin can serve multiple purposes, including patients with depression who also have symptoms suggestive of ADHD, as well as its FDA-approved role in smoking cessation as Zyban. NPZ discusses where Wellbutrin fits into treatment algorithms, when it works well as an augmentation strategy alongside SSRIs, and why understanding neurotransmitters is only one piece of becoming a confident psychiatric clinician.

Of course, no medication is perfect. We also cover important contraindications—including seizure disorders, eating disorders, CYP2D6 interactions, and common reasons patients discontinue Wellbutrin, such as increased anxiety or irritability. Most importantly, you'll learn how experienced clinicians think through these tradeoffs rather than simply memorizing medication facts.

Whether you're a PMHNP student, psychiatric nurse practitioner, psychiatry resident, physician assistant, psychiatrist, or another mental health professional looking to sharpen your psychopharmacology skills, this episode is packed with practical clinical pearls you can immediately apply in practice.

Topics Covered:

• Wellbutrin (Bupropion) Clinical Pearls
• Wellbutrin vs SSRIs
• Prozac vs Wellbutrin
• Zoloft vs Wellbutrin
• Lexapro vs Wellbutrin
• Depression with fatigue and low motivation
• Dopamine vs serotonin
• ADHD and Wellbutrin
• Smoking cessation (Zyban)
• Antidepressant sexual dysfunction
• Weight gain and antidepressants
• CYP2D6 drug interactions
• PMHNP education
• Psychopharmacology
• Psychiatric medication management
• Clinical reasoning for new psychiatric providers

🎧 If you're looking for practical psychopharmacology, memorable clinical pearls, and the kind of mentorship conversations that bridge the gap between textbooks and real-world psychiatry, you're in the right place.

32

The 6 Reasons Experienced Clinicians Reach for Wellbutrin First

Pearls and Prep

[email protected]

https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink

This podcast uses the following third-party services for analysis:

Podcorn - https://podcorn.com/privacy

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.”

Be the second on Patreon:

👉 https://www.patreon.com/PearlsandPrep

The primary focus of this discourse is the critical examination of antipsychotic medication switching, emphasizing the imperative considerations that must govern such transitions. We delve into the rationale behind a patient's desire to switch their antipsychotic, particularly addressing issues of efficacy and adverse side effects. It is paramount for clinicians to possess a comprehensive understanding of receptor dynamics and affinities, as these factors significantly influence the therapeutic decision-making process. Additionally, we illustrate the potential consequences of abrupt medication changes through a case study, which underscores the risks associated with inadequate cross-titration and the importance of maintaining an effective dopamine blockade. Throughout this episode, we aim to equip listeners with the knowledge necessary to navigate the complexities of antipsychotic management with confidence and precision.

26

Antipsychotic Switching: Key Concepts and Clinical Considerations

Pearls and Prep

[email protected]

https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink

JOIN!

The discourse presented in the podcast meticulously delves into the intricate process of switching antipsychotic medications, a subject of paramount importance in psychiatric practice. The speaker elucidates the various rationales for transitioning patients from one antipsychotic to another, highlighting factors such as diminished efficacy or intolerable side effects, which may compel both clinicians and patients to consider alternative therapeutic options. The discussion further emphasizes the necessity of understanding the pharmacodynamics of different antipsychotics, particularly the significance of receptor affinity, which varies among medications within the second-generation antipsychotic category. This knowledge is deemed essential for making informed clinical decisions that prioritize patient safety and therapeutic efficacy.

An illustrative case study involving a hypothetical patient, Lydia, provides a practical framework for understanding the complexities involved in medication switching. Lydia's case, characterized by a history of schizoaffective disorder and significant psychiatric episodes, serves to exemplify the high stakes associated with altering antipsychotic regimens, particularly when a patient has maintained relative stability on a specific medication for an extended period. The speaker articulates the critical importance of carefully assessing a patient’s psychiatric history and the potential ramifications of abrupt medication discontinuation, particularly regarding the risk of rebound psychosis and the necessity for adequate dopamine blockade. The conversation ultimately underscores the importance of a nuanced approach to medication management, advocating for a thorough consideration of both pharmacological properties and patient-specific factors before implementing treatment changes.

Takeaways:

• The process of switching antipsychotics requires a thorough understanding of receptor affinities and potential side effects.
• It is essential to consider the patient's psychiatric history and the stakes involved in the switch.
• Directly switching from one antipsychotic to another without a careful plan can lead to destabilization in the patient.
• Understanding the pharmacodynamics of medications like Risperdal and Seroquel is crucial for effective treatment management.
• The timing of medication transitions and the maintenance of effective dopamine blockade are critical aspects in managing patient care.
• Each antipsychotic has unique properties and must be evaluated based on individual patient needs and histories.

Companies mentioned in this episode:

• Risperdal
• Seroquel
• Abilify
• Geodon

This podcast uses the following third-party services for analysis:

Podcorn - https://podcorn.com/privacy

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.”

Patients know the difference. Know the WHY!

Join our clinical library today on PATREON!

👉 https://www.patreon.com/PearlsandPrep

The Grocery Store Trick That Will Change How You Understand Every Psychiatric Medication (Stop Memorizing CYP Enzymes Forever)

Every psychiatric medication can be understood by answering just two questions—and once you see them through the lens of a grocery store, you'll never look at psychopharmacology the same way again.

In this episode of Pearls & Prep, I introduce what I believe is the single most useful mental model for understanding CYP450 enzymes, pharmacokinetics, pharmacogenomics, and drug interactions without memorizing endless charts. Instead of rote memorization, you'll learn how to think like a clinician.

Using sertraline (Zoloft), escitalopram (Lexapro), and fluoxetine (Prozac) as examples, you'll finally understand:

• Why some medications have multiple "checkout lanes" while others depend on just one.
• Why Prozac causes so many clinically significant drug interactions.
• Why Lexapro is incredibly "clean" for other medications—but can become problematic in CYP2C19 poor metabolizers.
• Why Zoloft is often one of the most flexible and forgiving SSRIs in clinical practice.
• How to separate "How is MY drug metabolized?" from "Does MY drug interfere with OTHER drugs?"—two questions that every prescriber should ask before writing a prescription.

Whether you're a PMHNP student, psychiatry resident, PA, physician, pharmacist, or practicing psychiatric clinician, this episode will give you a visual framework that makes antidepressant prescribing easier, safer, and far more intuitive.

If you've ever felt overwhelmed by CYP enzymes, SSRI drug interactions, pharmacokinetics, or pharmacogenomics, this episode is for you.

Keywords: psychopharmacology, psychiatric medications, CYP450 enzymes, CYP2D6, CYP2C19, SSRI drug interactions, Prozac, fluoxetine, Lexapro, escitalopram, Zoloft, sertraline, antidepressants, pharmacokinetics, pharmacogenomics, medication metabolism, psychiatry, PMHNP, psychiatric nurse practitioner, medication interactions.

32

The Grocery Store Trick That Will Change How You Understand Every Psychiatric Medication (Stop Memorizing CYP Enzymes Forever)

Pearls and Prep

[email protected]

https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink

This podcast uses the following third-party services for analysis:

Podcorn - https://podcorn.com/privacy

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.”

Patients know the difference. Know the WHY!

Join our clinical library today on PATREON!

👉 https://www.patreon.com/PearlsandPrep

The Polarity Index may be one of the most underutilized concepts in bipolar disorder—and once you understand it, choosing maintenance medications becomes dramatically easier. In this episode, I break down the Polarity Index into plain language and show you how to stop memorizing drug lists and start thinking like an expert clinician.

You'll learn why acute treatment and maintenance treatment are not the same decision, how to identify a patient's predominant pole (mania vs. depression), and how that single insight can transform your medication selection. Through realistic mock patient cases, we'll walk through when to choose lamotrigine, lithium, quetiapine, aripiprazole, lurasidone, cariprazine, and Symbyax, while tying every decision back to receptor pharmacology and long-term relapse prevention.

In this episode you'll learn:

• What the Polarity Index actually measures
• The difference between acute stabilization and maintenance treatment
• How to identify a patient's predominant pole
• Why treating today's episode isn't always the same as preventing tomorrow's relapse
• When to choose lamotrigine, lithium, quetiapine, aripiprazole, lurasidone or cariprazine.
• The receptor mechanisms that explain why these medications work
• Clinical pearls that can immediately improve your bipolar prescribing

Whether you're a PMHNP student, psychiatry resident, psychiatric nurse practitioner, physician assistant, psychiatrist, or anyone looking to master psychopharmacology, this episode provides a practical framework you'll use every time you treat bipolar disorder.

OG article on polarity index: https://www.sciencedirect.com/science/article/abs/pii/S0924977X11002616?via%3Dihub

This podcast uses the following third-party services for analysis:

Podcorn - https://podcorn.com/privacy

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.”

Patients know the difference. Know the WHY!

Join our clinical library today on PATREON!

👉 https://www.patreon.com/PearlsandPrep

Why is Abilify used for major depressive disorder (MDD) augmentation if it isn't actually an antidepressant?

This is one of the most confusing concepts for psychiatric nurse practitioner students, physician assistants, psychiatry residents, medical students, and even new clinicians learning psychopharmacology.

In this Off the PHARM episode, we break down Abilify (aripiprazole) augmentation using a memorable visual analogy you'll never forget.

Imagine major depression as a clogged toilet.

The SSRI is the plumber—it comes in to fix the primary problem by increasing serotonin and treating depressive symptoms. But while doing its job, the plumber accidentally creates some collateral damage by bumping into other serotonin receptors, contributing to common SSRI side effects such as sexual dysfunction, nausea, gastrointestinal upset, appetite changes, weight gain, activation, and early anxiety.

That's where Abilify comes in.

Abilify doesn't "unclog the toilet" by itself. It isn't considered a traditional antidepressant for monotherapy in major depressive disorder. Instead, it serves as an augmentation strategy, helping optimize the overall system and improve outcomes when an SSRI alone isn't enough.

In this episode you'll learn:

• Why Abilify is FDA-approved as an adjunctive treatment for major depressive disorder.

• Why augmentation is different from antidepressant monotherapy.

• How SSRIs interact with multiple serotonin receptor subtypes.

• Why serotonin receptor activity contributes to both therapeutic benefits and adverse effects.

• A simple visual framework for remembering psychopharmacology during clinical practice and PMHNP board preparation.

• Practical prescribing pearls you can immediately apply in outpatient psychiatry.

Whether you're studying for the PMHNP boards, preparing for psychiatry exams, or simply want psychopharmacology explained in a way that finally sticks, this episode turns a difficult concept into an unforgettable visual story.

Keywords: Abilify, aripiprazole, SSRI, antidepressants, augmentation, adjunctive therapy, major depressive disorder, MDD, psychopharmacology, serotonin receptors, 5-HT2A, 5-HT2C, 5-HT3, 5-HT1A, psychiatric nurse practitioner, PMHNP, psychiatry boards, psych NP, depression treatment, visual learning, psychiatry education, dopamine, serotonin, medication side effects, board review.

32

Why Abilify Isn't an Antidepressant (But Helps with Depression)

Pearls and Prep

[email protected]

https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink

This podcast uses the following third-party services for analysis:

Podcorn - https://podcorn.com/privacy

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.”

Patients know the difference. Know the WHY!

Join our clinical library today on PATREON!

👉 https://www.patreon.com/PearlsandPrep

In this episode of Pearls & Prep, we tackle one of the highest-yield—but least discussed—concepts in bipolar disorder: the Polarity Index. If you've ever wondered why one maintenance medication seems to fit one bipolar patient perfectly while another falls flat, this episode gives you a practical framework you'll use for years.

We'll start by breaking down what the Polarity Index is, where it came from, and why researchers developed it in the first place. Then we'll introduce the concept of predominant polarity—a simple way to identify whether a patient's illness has historically been driven more by manic episodes or depressive episodes.

From there, I teach you the hard-and-fast rule that makes remembering this concept incredibly easy: high Polarity Index = better at preventing mania; low Polarity Index = better at preventing depression; values near 1 = balanced protection. Once you understand that rule, choosing and remembering maintenance medications becomes dramatically simpler.

We'll also review the polarity indices of several commonly used bipolar maintenance medications, discuss how to think about them clinically, highlight a few memorable patient examples, and finish with practical board pearls you can immediately apply in both exam questions and real-world practice.

Whether you're studying for the PMHNP boards, preparing for rotations, or simply want a cleaner mental framework for bipolar maintenance treatment, this episode will leave you with one of the most practical prescribing pearls in psychiatry.

Topics covered: Bipolar Disorder • Bipolar I Disorder • Polarity Index • Predominant Polarity • Bipolar Maintenance Treatment • Mood Stabilizers • Aripiprazole • Lamotrigine • Lithium • Quetiapine • PMHNP Boards • Psychiatry Education • Psychopharmacology • Clinical Pearls • Psychiatric Nurse Practitioner

32

Why Your Bipolar Patient Keeps Relapsing: The Polarity Index

Pearls and Prep

[email protected]

https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink

This podcast uses the following third-party services for analysis:

Podcorn - https://podcorn.com/privacy